part of the brain on memory, which depended on a different region of the brain.
Was sleep disruption the missing factor?
To test this theory, we had elderly patients with varying levels of amyloid—low
to high—in their brains learn a list of new facts in the evening. The next morning,
after recording their sleep in the laboratory that night, we tested them to see how
effective their sleep had been at cementing and thus holding on to those new
memories. We discovered a chain-reaction effect. Those individuals with the
highest levels of amyloid deposits in the frontal regions of the brain had the most
severe loss of deep sleep and, as a knock-on consequence, failed to successfully
consolidate those new memories. Overnight forgetting, rather than remembering,
had taken place. The disruption of deep NREM sleep was therefore a hidden
middleman brokering the bad deal between amyloid and memory impairment in
Alzheimer’s disease. A missing link.
These findings, however, were only half of the story, and admittedly the less
important half. Our work had shown that the amyloid plaques of Alzheimer’s
disease may be associated with the loss of deep sleep, but does it work both ways?
Can a lack of sleep actually cause amyloid to build up in your brain to begin with?
If so, insufficient sleep across an individual’s life would significantly raise their
risk of developing Alzheimer’s disease.
Around the same time that we were conducting our studies, Dr. Maiken
Nedergaard at the University of Rochester made one of the most spectacular
discoveries in the field of sleep research in recent decades. Working with mice,
Nedergaard found that a kind of sewage network called the glymphatic system
exists within the brain. Its name is derived from the body’s equivalent lymphatic
system, but it’s composed of cells called glia (from the Greek root word for “glue”).
Glial cells are distributed throughout your entire brain, situated side by side
with the neurons that generate the electrical impulses of your brain. Just as the
lymphatic system drains contaminants from your body, the glymphatic system
collects and removes dangerous metabolic contaminants generated by the hard
work performed by neurons in your brain, rather like a support team surrounding
an elite athlete.
Although the glymphatic system—the support team—is somewhat active
during the day, Nedergaard and her team discovered that it is during sleep that
this neural sanitization work kicks into high gear. Associated with the pulsing
rhythm of deep NREM sleep comes a ten- to twentyfold increase in effluent
expulsion from the brain. In what can be described as a nighttime power cleanse,
the purifying work of the glymphatic system is accomplished by cerebrospinal
fluid that bathes the brain.
Nedergaard made a second astonishing discovery, which explained why the
cerebrospinal fluid is so effective in flushing out metabolic debris at night. The
glial cells of the brain were shrinking in size by up to 60 percent during NREM
sleep, enlarging the space around the neurons and allowing the cerebrospinal
fluid to proficiently clean out the metabolic refuse left by the day’s neural activity.
Think of the buildings of a large metropolitan city physically shrinking at night,
allowing municipal cleaning crews easy access to pick up garbage strewn in the
streets, followed by a good pressure-jet treatment of every nook and cranny.
When we wake each morning, our brains can once again function efficiently
thanks to this deep cleansing.
So what does this have to do with Alzheimer’s disease? One piece of toxic
debris evacuated by the glymphatic system during sleep is amyloid protein—the
poisonous element associated with Alzheimer’s disease. Other dangerous
metabolic waste elements that have links to Alzheimer’s disease are also removed
by the cleaning process during sleep, including a protein called tau, as well as
stress molecules produced by neurons when they combust energy and oxygen
during the day. Should you experimentally prevent a mouse from getting NREM
sleep, keeping it awake instead, there is an immediate increase in amyloid
deposits within the brain. Without sleep, an escalation of poisonous Alzheimer’s-
related protein accumulated in the brains of the mice, together with several other
toxic metabolites. Phrased differently, and perhaps more simply, wakefulness is
low-level brain damage, while sleep is neurological sanitation.
Nedergaard’s findings completed the circle of knowledge that our findings had
left unanswered. Inadequate sleep and the pathology of Alzheimer’s disease
interact in a vicious cycle. Without sufficient sleep, amyloid plaques build up in
the brain, especially in deep-sleep-generating regions, attacking and degrading
them. The loss of deep NREM sleep caused by this assault therefore lessens the
ability to remove amyloid from the brain at night, resulting in greater amyloid
deposition. More amyloid, less deep sleep, less deep sleep, more amyloid, and so
on and so forth.
From this cascade comes a prediction: getting too little sleep across the adult
life span will significantly raise your risk of developing Alzheimer’s disease.
Precisely this relationship has now been reported in numerous epidemiological
studies, including those individuals suffering from sleep disorders such as
insomnia and sleep apnea.
VIII
Parenthetically, and unscientifically, I have always
found it curious that Margaret Thatcher and Ronald Reagan—two heads of state
that were very vocal, if not proud, about sleeping only four to five hours a night—
both went on to develop the ruthless disease. The current US president, Donald
Trump—also a vociferous proclaimer of sleeping just a few hours each night—
may want to take note.
A more radical and converse prediction that emerges from these findings is
that, by improving someone’s sleep, we should be able to reduce their risk of
developing Alzheimer’s disease—or at least delay its onset. Tentative support has
emerged from clinical studies in which middle- and older-age adults have had
their sleep disorders successfully treated. As a consequence, their rate of
cognitive decline slowed significantly, and further delayed the onset of
Alzheimer’s disease by five to ten years.
IX
My own research group is now trying to develop a number of viable methods
for artificially increasing deep NREM sleep that could restore some degree of the
memory consolidation function that is absent in older individuals with high
amounts of amyloid in the brain. If we can find a method that is cost effective and
can be scaled up to the population level for repeat use, my goal is prevention. Can
we begin supplementing the declining deep sleep of vulnerable members of
society during midlife, many decades before the tipping point of Alzheimer’s
disease is reached, aiming to avert dementia risk later in life? It is an admittedly
lofty ambition, and some would argue a moon shot research goal. But it is worth
recalling that we already use this conceptual approach in medicine in the form of
prescribing statins to higher-risk individuals in their forties and fifties to help
prevent cardiovascular disease, rather than having to treat it decades later.
Insufficient sleep is only one among several risk factors associated with
Alzheimer’s disease. Sleep alone will not be the magic bullet that eradicates
dementia. Nevertheless, prioritizing sleep across the life span is clearly becoming
a significant factor for lowering Alzheimer’s disease risk.
I
. Foundation for Traffic Safety. “Acute Sleep Deprivation and Crash Risk,” accessed at
https://www.aaafoundation.org/acute-sleep-deprivation-and-crash-risk
.
II
. Common myths that are of no use in helping to overcome drowsiness while driving include: turning up
the radio, winding down the car window, blowing cold air on your face, splashing cold water on your face,
talking on the phone, chewing gum, slapping yourself, pinching yourself, punching yourself, and promising
yourself a reward for staying awake.
III
. Also known as DEC2.
IV
. K. J. Brower and B. E. Perron, “Sleep disturbance as a universal risk factor for relapse in addictions to
psychoactive substances,” Medical Hypotheses 74, no. 5 (2010): 928–33; D. A. Ciraulo, J. Piechniczek-Buczek,
and E. N. Iscan, “Outcome predictors in substance use disorders,” Psychiatric Clinics of North America 26, no.
2 (2003): 381–409; J. E. Dimsdale, D. Norman, D. DeJardin, and M. S. Wallace, “The effect of opioids on sleep
architecture,” Journal of Clinical Sleep Medicine 3, no. 1 (2007): 33–36; E. F. Pace-Schott, R. Stickgold, A.
Muzur, P. E. Wigren, et al., “Sleep quality deteriorates over a binge-abstinence cycle in chronic smoked
cocaine users,” Psychopharmacology (Berl) 179, no. 4 (2005): 873–83; and J. T. Arnedt, D. A. Conroy, and K. J.
Brower, “Treatment options for sleep disturbances during alcohol recovery,” Journal of Addictive Diseases 26,
no. 4 (2007): 41–54.
V
. K. J. Brower and B. E. Perron, “Sleep disturbance as a universal risk factor for relapse in addictions to
psychoactive substances,” Medical Hypotheses 74, no. 5 (2010): 928–33.
VI
. N. D. Volkow, D. Tomasi, G. J. Wang, F. Telang, et al., “Hyperstimulation of striatal D2 receptors with sleep
deprivation: Implications for cognitive impairment,” NeuroImage 45, no. 4 (2009): 1232–40.
VII
. Cossman had other pearls of wisdom, too, such as “The best way to remember your wife’s birthday is to
forget it once.”
VIII
. A. S. Lim et al., “Sleep Fragmentation and the Risk of Incident Alzheimer’s Disease and Cognitive
Decline in Older Persons,” Sleep 36 (2013): 1027–32; A. S. Lim et al., “Modification of the relationship of the
apolipoprotein E epsilon4 allele to the risk of Alzheimer’s disease and neurofibrillary tangle density by
sleep,” JAMA Neurology 70 (2013): 1544–51; R. S. Osorio et al., “Greater risk of Alzheimer’s disease in older
adults with insomnia,” Journal of the American Geriatric Society 59 (2011): 559–62; and K. Yaffe et al., “Sleep-
disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women,” JAMA
306 (2011): 613–19.
IX
. S. Ancoli-Israel et al., “Cognitive effects of treating obstructive sleep apnea in Alzheimer’s disease: a
randomized controlled study,” Journal of the American Geriatric Society 56 (2008): 2076–81; and W.d.S. Moraes
et al., “The effect of donepezil on sleep and REM sleep EEG in patients with Alzheimer’s disease: a double-
blind placebo-controlled study,” Sleep 29 (2006): 199–205.
CHAPTER 8
Cancer, Heart Attacks, and a Shorter Life
Sleep Deprivation and the Body
I was once fond of saying, “Sleep is the third pillar of good health, alongside diet
and exercise.” I have changed my tune. Sleep is more than a pillar; it is the
foundation on which the other two health bastions sit. Take away the bedrock of
sleep, or weaken it just a little, and careful eating or physical exercise become less
than effective, as we shall see.
Yet the insidious impact of sleep loss on health runs much deeper. Every major
system, tissue, and organ of your body suffers when sleep becomes short. No
aspect of your health can retreat at the sign of sleep loss and escape unharmed.
Like water from a burst pipe in your home, the effects of sleep deprivation will
seep into every nook and cranny of biology, down into your cells, even altering
your most fundamental self—your DNA.
Widening the lens of focus, there are more than twenty large-scale
epidemiological studies that have tracked millions of people over many decades,
all of which report the same clear relationship: the shorter your sleep, the shorter
your life. The leading causes of disease and death in developed nations—diseases
that are crippling health-care systems, such as heart disease, obesity, dementia,
diabetes, and cancer—all have recognized causal links to a lack of sleep.
This chapter describes, uncomfortably, the many and varied ways in which
insufficient sleep proves ruinous to all the major physiological systems of the
human body: cardiovascular, metabolic, immune, reproductive.
SLEEP LOSS AND THE CARDIOVASCULAR SYSTEM
Unhealthy sleep, unhealthy heart. Simple and true. Take the results of a 2011
study that tracked more than half a million men and women of varied ages, races,
and ethnicities across eight different countries. Progressively shorter sleep was
associated with a 45 percent increased risk of developing and/or dying from
coronary heart disease within seven to twenty-five years from the start of the
study. A similar relationship was observed in a Japanese study of over 4,000 male
workers. Over a fourteen-year period, those sleeping six hours or less were 400 to
500 percent more likely to suffer one or more cardiac arrests than those sleeping
more than six hours. I should note that in many of these studies, the relationship
between short sleep and heart failure remains strong even after controlling for
other known cardiac risk factors, such as smoking, physical activity, and body
mass. A lack of sleep more than accomplishes its own, independent attack on the
heart.
As we approach midlife, and our body begins to deteriorate and health
resilience starts its decline, the impact of insufficient sleep on the cardiovascular
system escalates. Adults forty-five years or older who sleep fewer than six hours a
night are 200 percent more likely to have a heart attack or stroke during their
lifetime, as compared with those sleeping seven to eight hours a night. This
finding impresses how important it is to prioritize sleep in midlife—which is
unfortunately the time when family and professional circumstances encourage us
to do the exact opposite.
Do'stlaringiz bilan baham: |